Home/Filings/4/0001213900-23-019387
4//SEC Filing

COLEMAN KIRK ALLEN 4

Accession 0001213900-23-019387

CIK 0001733413other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 8:00 AM ET

Size

5.0 KB

Accession

0001213900-23-019387

Insider Transaction Report

Form 4
Period: 2023-03-10
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
Transactions
  • Purchase

    Common Stock

    2023-03-10$0.79/sh+12,000$9,45715,675 total
Footnotes (1)
  • [F1]The reported shares were purchased in the open market in multiple transactions at prices ranging from $0.7848 to $0.7888. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Documents

1 file

Issuer

TFF Pharmaceuticals, Inc.

CIK 0001733413

Entity typeother

Related Parties

1
  • filerCIK 0001790624

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:00 AM ET
Size
5.0 KB